4//SEC Filing
Wells David R. 4
Accession 0001209191-20-005185
CIK 0001681682other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:02 PM ET
Size
5.4 KB
Accession
0001209191-20-005185
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Award
Stock Options
2020-01-25+20,000→ 20,000 totalExercise: $1.71Exp: 2030-01-25→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 25, 2021.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 5:02 PM ET
- Size
- 5.4 KB